Signal · Product Feed

Trelagliptin succinate A tert-Butyl ester LY-2090314 enhances the efficacy of

Trelagliptin succinate A tert-Butyl ester LY-2090314 enhances the efficacy of

Name: Trelagliptin succinate A tert-Butyl ester LY-2090314 enhances the efficacy of
Brand: www.cleversources.com
SKU: 12585729509
Price: 36.00 USD
Availability: InStock
Rating: 4.3267 (17 reviews)

SKU: 12585729509

4.3

USD36.00 USD68.00

Pay in 4 interest-free payments of $9.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Live Spec

Trelagliptin succinate A tert-Butyl ester LY-2090314 enhances the efficacy ofTrelagliptin, also known as SYR 472, is a long acting dipeptidyl peptidase 4 (DPP 4) inhibitor that is being developed by Takeda for the treatment of type 2 diabetes (T2D). Once weekly SYR 472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. It was well tolerated and might be a new treatment option for patients with this disease. Trelagliptin (Zafatek()) was approved in

Store: www.cleversources.com · Domain: www.cleversources.com

Description

LY-2090314 enhances the efficacy of cisplatin and carboplatin in solid tumor cancer xenografts

Chemical Name: 3-chloro-N-((1r

1038/s41587-019-0082-6

physostigmine

Exchange/Return Notes